Antithrombin alternatives in STEMI.
Publication
, Journal Article
Stone, GW; Ohman, EM
Published in: Lancet
August 20, 2011
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Lancet
DOI
EISSN
1474-547X
Publication Date
August 20, 2011
Volume
378
Issue
9792
Start / End Page
643 / 645
Location
England
Related Subject Headings
- Myocardial Infarction
- Injections, Intravenous
- Humans
- Heparin
- General & Internal Medicine
- Fibrinolytic Agents
- Enoxaparin
- Electrocardiography
- Anticoagulants
- Angioplasty, Balloon, Coronary
Citation
APA
Chicago
ICMJE
MLA
NLM
Stone, G. W., & Ohman, E. M. (2011). Antithrombin alternatives in STEMI. Lancet, 378(9792), 643–645. https://doi.org/10.1016/S0140-6736(11)61059-3
Stone, Gregg W., and E Magnus Ohman. “Antithrombin alternatives in STEMI.” Lancet 378, no. 9792 (August 20, 2011): 643–45. https://doi.org/10.1016/S0140-6736(11)61059-3.
Stone GW, Ohman EM. Antithrombin alternatives in STEMI. Lancet. 2011 Aug 20;378(9792):643–5.
Stone, Gregg W., and E. Magnus Ohman. “Antithrombin alternatives in STEMI.” Lancet, vol. 378, no. 9792, Aug. 2011, pp. 643–45. Pubmed, doi:10.1016/S0140-6736(11)61059-3.
Stone GW, Ohman EM. Antithrombin alternatives in STEMI. Lancet. 2011 Aug 20;378(9792):643–645.
Published In
Lancet
DOI
EISSN
1474-547X
Publication Date
August 20, 2011
Volume
378
Issue
9792
Start / End Page
643 / 645
Location
England
Related Subject Headings
- Myocardial Infarction
- Injections, Intravenous
- Humans
- Heparin
- General & Internal Medicine
- Fibrinolytic Agents
- Enoxaparin
- Electrocardiography
- Anticoagulants
- Angioplasty, Balloon, Coronary